Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-005844
Filing Date
2013-01-31
Accepted
2013-01-31 17:10:47
Documents
1
Period of Report
2013-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd368097.html 4  
1 FORM 4 rrd368097.xml 4 5466
  Complete submission text file 0001181431-13-005844.txt   6915
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 353 1 709 4700
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA CORPORATION PLC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Fawcett John Randall (Reporting) CIK: 0001564384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 13563454